Investors Capital Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$2.17M Buy
39,523
+592
+2% +$31.5K 0.42% 53
2016
Q1
$1.96M Buy
38,931
+274
+0.7% +$13.4K 0.39% 55
2015
Q4
$1.95M Sell
38,657
-3,055
-7% -$154K 0.38% 55
2015
Q3
$1.96M Buy
41,712
+1,366
+3% +$72.6K 0.39% 47
2015
Q2
$2.19M Buy
40,346
+51
+0.1% +$2.86K 0.4% 42
2015
Q1
$2.21M Sell
40,295
-6,146
-13% -$348K 0.41% 37
2014
Q4
$2.52M Buy
46,441
+2,553
+6% +$142K 0.48% 32
2014
Q3
$2.48M Buy
43,888
+162
+0.4% +$9.1K 0.49% 31
2014
Q2
$2.41M Buy
43,726
+1,598
+4% +$87.2K 0.39% 47
2014
Q1
$2.28M Buy
42,128
+2,021
+5% +$105K 0.49% 33
2013
Q4
$1.92M Buy
40,107
+224
+0.6% +$10.2K 0.45% 40
2013
Q3
$1.81M Buy
39,883
+3,764
+10% +$172K 0.47% 39
2013
Q2
$1.6M Buy
+36,119
New +$1.61M 0.49% 42

Other funds holding MRK

Investors Capital Advisory Services's MRK Position: Q2 2016 in Review

Investors Capital Advisory Services increased its Merck (MRK) stake by 1.5% in Q2 2016, buying an estimated $31.5K and bringing the position to 39,523 shares worth $2.17M. The position accounts for 0.42% of the portfolio, ranked #53.

Investors Capital Advisory Services first reported a position in MRK in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.52M in Q4 2014. 1,761 funds tracked by Wall St. Rank hold MRK as of Q2 2016.

  • Investors Capital Advisory Services held 39,523 shares of Merck worth $2.17M as of Q2 2016.
  • Investors Capital Advisory Services bought 592 Merck shares in Q2 2016, an estimated $31.5K.
  • Merck made up 0.42% of Investors Capital Advisory Services's portfolio in Q2 2016, its #53 holding.
  • Investors Capital Advisory Services first reported a position in Merck in Q2 2013 and has held it in 13 quarters since.
  • Investors Capital Advisory Services's Merck position peaked at $2.52M in Q4 2014.
  • 1,761 funds tracked by Wall St. Rank held Merck as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.